AmerisourceBergen Corp (ABC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Nov 03, 2022: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
Sep 13, 2022: AmerisourceBergen agrees to acquire PharmaLex for $1.29bn
Sep 06, 2022: HHS Awards $20 million contract to AmerisourceBergen to expand, quicken distribution of vaccines and treatments for monkeypox
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
AmerisourceBergen Corp (AmerisourceBergen) is a pharmaceutical sourcing and distribution services company that offers pharmaceutical products, business solutions, and value-driving services that improve access to care. The company distributes a broad offering of brand-name, specialty brand-name, over-the-counter(OTC) healthcare products, generic pharmaceuticals, equipment, home healthcare supplies, outsourced compounded sterile preparations, and related services. It serves numerous healthcare providers in the US and selected global markets, comprising independent and chain retail pharmacies, acute care hospitals and health systems, medical clinics, mail-order pharmacies, medical and dialysis clinics, physician practices, long-term care and alternate site pharmacies, veterinarians, and other customers. AmerisourceBergen is headquartered in Conshohocken, Pennsylvania, the US.AmerisourceBergen Corp Key Recent Developments
Dec 29, 2022: Justice department files nationwide lawsuit against AmerisourceBergen and subsidiaries for controlled substances act violationsNov 03, 2022: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
Sep 13, 2022: AmerisourceBergen agrees to acquire PharmaLex for $1.29bn
Sep 06, 2022: HHS Awards $20 million contract to AmerisourceBergen to expand, quicken distribution of vaccines and treatments for monkeypox
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company- AmerisourceBergen Corp - Key Facts
- AmerisourceBergen Corp - Key Employees
- AmerisourceBergen Corp - Key Employee Biographies
- AmerisourceBergen Corp - Major Products and Services
- AmerisourceBergen Corp - History
- AmerisourceBergen Corp - Company Statement
- AmerisourceBergen Corp - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Company Overview
- AmerisourceBergen Corp - Business Description
- Business Segment: International Healthcare Solutions
- Overview
- Performance
- Business Segment: The US Healthcare Solutions
- Overview
- Performance
- AmerisourceBergen Corp - Corporate Strategy
- AmerisourceBergen Corp - SWOT Analysis
- SWOT Analysis - Overview
- AmerisourceBergen Corp - Strengths
- AmerisourceBergen Corp - Weaknesses
- AmerisourceBergen Corp - Opportunities
- AmerisourceBergen Corp - Threats
- AmerisourceBergen Corp - Key Competitors
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- AmerisourceBergen Corp, Recent Deals Summary
- Dec 29, 2022: Justice department files nationwide lawsuit against AmerisourceBergen and subsidiaries for controlled substances act violations
- Nov 03, 2022: AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results
- Sep 13, 2022: AmerisourceBergen agrees to acquire PharmaLex for $1.29bn
- Sep 06, 2022: HHS Awards $20 million contract to AmerisourceBergen to expand, quicken distribution of vaccines and treatments for monkeypox
- Aug 03, 2022: AmerisourceBergen Reports Fiscal 2022 Third Quarter Results
- Jul 27, 2022: AmerisourceBergen to launch digital therapeutics platform to facilitate access to innovative products
- Jun 14, 2022: Fresenius Kabi expands RFID compatibility to improve hospital inventory management
- Jun 01, 2022: AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day
- May 24, 2022: AmerisourceBergen unveils Clinical Trial Navigator to boost community-based research
- May 04, 2022: AmerisourceBergen Reports Fiscal 2022 Second Quarter Results
- Methodology
- Ratio Definitions
- About the Publisher
- Contact the Publisher
- Disclaimer
- AmerisourceBergen Corp, Key Facts
- AmerisourceBergen Corp, Key Employees
- AmerisourceBergen Corp, Key Employee Biographies
- AmerisourceBergen Corp, Major Products and Services
- AmerisourceBergen Corp, History
- AmerisourceBergen Corp, Subsidiaries
- AmerisourceBergen Corp, Key Competitors
- AmerisourceBergen Corp, Ratios based on current share price
- AmerisourceBergen Corp, Annual Ratios
- AmerisourceBergen Corp, Interim Ratios
- AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023
- AmerisourceBergen Corp, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- AmerisourceBergen Corp, Performance Chart (2017 - 2021)
- AmerisourceBergen Corp, Ratio Charts
- AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023
- AmerisourceBergen Corp, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- United Parcel Service Inc
- MediPal Holdings Corp
- McKesson Corp
- Henry Schein Inc
- Cardinal Health Inc
